119 related articles for article (PubMed ID: 31833168)
21. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
Sridharan P; Chamberlain RS
Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
[TBL] [Abstract][Full Text] [Related]
22. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
23. Early identification of acute heart failure at the time of presentation: do natriuretic peptides make the difference?
Möckel M; von Haehling S; Vollert JO; Wiemer JC; Anker SD; Maisel A;
ESC Heart Fail; 2018 Jun; 5(3):309-315. PubMed ID: 29667356
[TBL] [Abstract][Full Text] [Related]
24. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M
Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195
[TBL] [Abstract][Full Text] [Related]
25. Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study.
Maseda E; Suarez-de-la-Rica A; Anillo V; Tamayo E; García-Bernedo CA; Ramasco F; Villagran MJ; Maggi G; Gimenez MJ; Aguilar L; Granizo JJ; Buño A; Gilsanz F
J Crit Care; 2015 Jun; 30(3):537-42. PubMed ID: 25600574
[TBL] [Abstract][Full Text] [Related]
26. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
[TBL] [Abstract][Full Text] [Related]
27. Impact of Pharmacist-Led Procalcitonin-Guided Antibiotic Therapy in Critically Ill Patients With Pneumonia.
Subedi B; Louzon P; Zappas K; Onyia W; DeBoer K
Hosp Pharm; 2020 Jun; 55(3):204-210. PubMed ID: 32508359
[No Abstract] [Full Text] [Related]
28. PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): study protocol for a randomised controlled trial.
Siriwardena AK; Jegatheeswaran S; Mason JM; Baltatzis M; Chan A; Sheen AJ; O'Reilly D; Jamdar S; Deshpande R; de Liguori Carino N; Satyadas T; Qamruddin A; Hayden K; Parker MJ; Butler J; Rajai A; McIntyre B
Trials; 2019 Jul; 20(1):463. PubMed ID: 31358032
[TBL] [Abstract][Full Text] [Related]
29. Reduced utility of early procalcitonin and blood culture determination in patients with febrile urinary tract infections in the emergency department.
Covino M; Manno A; Merra G; Simeoni B; Piccioni A; Carbone L; Forte E; Ojetti V; Franceschi F; Murri R
Intern Emerg Med; 2020 Jan; 15(1):119-125. PubMed ID: 31650435
[TBL] [Abstract][Full Text] [Related]
30. Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.
Meier MA; Branche A; Neeser OL; Wirz Y; Haubitz S; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Christ-Crain M; Corti C; Jensen JS; Deliberato RO; Kristoffersen KB; Damas P; Nobre V; Oliveira CF; Shehabi Y; Stolz D; Tamm M; Mueller B; Schuetz P
Clin Infect Dis; 2019 Jul; 69(3):388-396. PubMed ID: 30358811
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
32. The Role of Early Procalcitonin Determination in the Emergency Departiment in Adults Hospitalized with Fever.
Covino M; Gallo A; Montalto M; De Matteis G; Burzo ML; Simeoni B; Murri R; Candelli M; Ojetti V; Franceschi F
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33669753
[No Abstract] [Full Text] [Related]
33. Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: a patient-level meta-analysis from randomized controlled trials.
Heilmann E; Gregoriano C; Annane D; Reinhart K; Bouadma L; Wolff M; Chastre J; Luyt CE; Tubach F; Branche AR; Briel M; Christ-Crain M; Welte T; Corti C; de Jong E; Nijsten M; de Lange DW; van Oers JAH; Beishuizen A; Girbes ARJ; Deliberato RO; Schroeder S; Kristoffersen KB; Layios N; Damas P; Lima SSS; Nobre V; Wei L; Oliveira CF; Shehabi Y; Stolz D; Tamm M; Verduri A; Wang JX; Drevet S; Gavazzi G; Mueller B; Schuetz P
Age Ageing; 2021 Sep; 50(5):1546-1556. PubMed ID: 33993243
[TBL] [Abstract][Full Text] [Related]
34. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
[TBL] [Abstract][Full Text] [Related]
35. Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure: The GALACTIC Randomized Clinical Trial.
Kozhuharov N; Goudev A; Flores D; Maeder MT; Walter J; Shrestha S; Gualandro DM; de Oliveira Junior MT; Sabti Z; Müller B; Noveanu M; Socrates T; Ziller R; Bayés-Genís A; Sionis A; Simon P; Michou E; Gujer S; Gori T; Wenzel P; Pfister O; Conen D; Kapos I; Kobza R; Rickli H; Breidthardt T; Münzel T; Erne P; Mueller C; ; Mueller C; Erne P; Müller B; Rickli H; Maeder M; Tavares de Oliveira M; Münzel T; Bayés-Genís A; Sionis A; Goudev A; Dimov B; Hartwiger S; Arenja N; Glatz B; Herr N; Isenrich R; Mosimann T; Twerenbold R; Boeddinghaus J; Nestelberger T; Puelacher C; Freese M; Vögele J; Meissner K; Martin J; Strebel I; Wussler D; Schumacher C; Osswald S; Vogt F; Hilti J; Barata S; Schneider D; Schwarz J; Fitze B; Hartwiger S; Arenja N; Glatz B; Herr N; Isenrich R; Mosimann T; Twerenbold R; Boeddinghaus J; Nestelberger T; Puelacher C; Freese M; Vögele J; Meissner K; Martin J; Strebel I; Wussler D; Schumacher C; Osswald S; Vogt F; Hilti J; Barata S; Schneider D; Schwarz J; Fitze B; Arenja N; Rentsch K; Bossa A; Jallad S; Soeiro A; Georgiev D; Jansen T; Gebel G; Bossard M; Christ M
JAMA; 2019 Dec; 322(23):2292-2302. PubMed ID: 31846016
[TBL] [Abstract][Full Text] [Related]
36. Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide for Prognosis in Septic Acute Kidney Injury Patients Receiving Renal Replacement Therapy.
Sheng X; Yang J; Yu G; Fei Y; Bao H; Yin J; Huang W; Tian Z; Wang N; Ronco C
Blood Purif; 2019; 48(3):262-271. PubMed ID: 31311006
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
[TBL] [Abstract][Full Text] [Related]
38. Higher diagnostic accuracy and cost-effectiveness using procalcitonin in the treatment of emergency medicine patients with fever (The HiTEMP study): a multicenter randomized study.
van der Does Y; Limper M; Schuit SC; Poley MJ; van Rosmalen J; Ramakers C; Patka P; van Gorp EC; Rood PP
BMC Emerg Med; 2016 Apr; 16():17. PubMed ID: 27048405
[TBL] [Abstract][Full Text] [Related]
39. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
